Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

International Biotechnology Trust

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 6
Rounds per year 0.26
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Health Diagnostics
  • Developer Platform
Summary

In 1994 was created International Biotechnology Trust, which is appeared as Corporate Investor. The fund was located in Europe if to be more exact in United Kingdom. The main department of described Corporate Investor is located in the London.

The higher amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this International Biotechnology Trust works on 21 percentage points more the average amount of lead investments. The top activity for fund was in 2001.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the International Biotechnology Trust, startups are often financed by SV Health Investors, New Hill Management, IP Group Plc. The meaningful sponsors for the fund in investment in the same round are SV Health Investors, Temasek Holdings, Singapore Bio-Innovations. In the next rounds fund is usually obtained by SV Health Investors, Alta Partners, Skyline Ventures.

Among the various public portfolio startups of the fund, we may underline eBioinformatics, Karus Therapeutics, Aderis Pharmaceuticals For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of International Biotechnology Trust:
Typical Co-investors
International Biotechnology Trust is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after International Biotechnology Trust:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerator Life Science Partners -
Daegyo Investment -
Danisco A/S Copenhagen, Denmark, Hovedstaden
EastWest VentureGroup California, Los Angeles, United States
Jiangxing Shiye China, Futian, Guangdong
Jiesi Hanneng China, Huangpu, Shanghai
KCK New York, New York, United States
Shenzhen Riwei Investment China, Guangdong, Shenzhen
Southern Raytai Group -
Vancouver Angel Forum -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Karus Therapeutics

Biotechnology
Life Science
Pharmaceutical
$7M06 Sep 2012 England

Oxagen

Biopharma
Biotechnology
Pharmaceutical
$26M24 Nov 2009 London, England, United Kingdom

Sutro Biopharma

Biotechnology
Information Technology
Medical
$305K16 Oct 2007 South San Francisco, California, United States

GlycoFi Inc.

Biotechnology
Health Care
$11M09 Oct 2005 New Hampshire, United States

Oxagen

Biopharma
Biotechnology
Pharmaceutical
$59M23 May 2005 London, England, United Kingdom

Aderis Pharmaceuticals

Biopharma
Biotechnology
Developer Platform
Health Diagnostics
$45M09 Oct 2001 Richmond, Virginia, United States

eBioinformatics

Bioinformatics
Biotechnology
Information Services
$10M30 May 2000 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent International Biotechnology Trust?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: